Clonazafone desglycyl

Clonazafone desglycyl
Identifiers
  • 2-amino-N-[2-(2-chlorobenzoyl)-4-nitrophenyl]acetamide
CAS Number
PubChem CID
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC15H12ClN3O4
Molar mass333.73 g·mol−1
3D model (JSmol)
  • C1=CC=C(C(=C1)C(=O)C2=C(C=CC(=C2)[N+](=O)[O-])NC(=O)CN)Cl
  • InChI=1S/C15H12ClN3O4/c16-12-4-2-1-3-10(12)15(21)11-7-9(19(22)23)5-6-13(11)18-14(20)8-17/h1-7H,8,17H2,(H,18,20)
  • Key:VDWHFAAXPZFFEI-UHFFFAOYSA-N

Clonazafone desglycyl (AC1Miehr) is a chemical compound that can act as both a prodrug and a synthetic precursor for the benzodiazepine derivative clonazepam.[1] It has been detected as a designer drug, first being identified in Germany in September 2024.[2]

See also

References

  1. ^ Gao X, Xu J, Liu C, Peng P, Zhao C, Chen M, et al. (April 2022). "Development of an Improved Synthetic Process of Clonazepam by Preventing the Formation of a Trimeric Compound in the Presence of HCl". Organic Process Research & Development. 26 (4): 1318–1326. doi:10.1021/acs.oprd.2c00023.
  2. ^ "European Drug Report 2025 – Full Book" (PDF). European Union Drugs Agency (euda.europa.eu). 6 June 2025.
This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.